Algerian study reveals hidden toll of COVID-19 on diabetic patients
NCT ID NCT07560059
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 201 adults with diabetes who were hospitalized for COVID-19 in Algeria. Researchers tracked their blood sugar, weight, and kidney function for up to a year after leaving the hospital. The goal was to learn how COVID-19 affects long-term diabetes control and to help doctors improve follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Djillali Belkhenchir Public Hospital (formerly Birtraria)
Algiers, El Biar, Algeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- FitBit coaching may help amputees walk more after surgery
- Can a new drug shield lungs from COVID-19's worst damage?